Insider · CIK 0001286102

LEONHARDT HARRY J

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001286102

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-08	Poseida Therapeutics, Inc.U Disposition from Tender	GC & Chief Compliance Officer	UDisposition from Tender	−224K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC & Chief Compliance Officer	DDisposition to Issuer	−160K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC & Chief Compliance Officer	DDisposition to Issuer	−137K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC & Chief Compliance Officer	DDisposition to Issuer	−72.6K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC & Chief Compliance Officer	DDisposition to Issuer	−125K sh	—	—	0
2025-01-08	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	GC & Chief Compliance Officer	DDisposition to Issuer	−112K sh	—	—	0
2024-03-01	Poseida Therapeutics, Inc.A Award	GC & Chief Compliance Officer	AAward	+80.7K sh	—	—	230,946
2024-03-01	Poseida Therapeutics, Inc.F Tax Payment	GC & Chief Compliance Officer	FTax Payment	−16.3K sh	$4.13	−$67.3K	214,640
2024-03-01	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	GC & Chief Compliance Officer	AAward	+112K sh	—	—	111,700
2023-03-01	Poseida Therapeutics, Inc.A Award	GC & Chief Compliance Officer	AAward	+92.8K sh	—	—	148,526
2023-03-01	Poseida Therapeutics, Inc.F Tax Payment	GC & Chief Compliance Officer	FTax Payment	−4,323 sh	$5.35	−$23.1K	144,203
2023-03-01	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	GC & Chief Compliance Officer	AAward	+125K sh	—	—	125,283
2022-03-01	Poseida Therapeutics, Inc.A Award	GC & Chief Compliance Officer	AAward	+50K sh	—	—	50,000
2022-03-01	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	GC & Chief Compliance Officer	AAward	+72.6K sh	—	—	72,568
2021-02-04	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	GC & Chief Compliance Officer	AAward	+137K sh	—	—	137,000
2019-04-13	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+6,875 sh	—	—	68,750
2019-04-13	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−2,377 sh	$16.54	−$39.3K	66,373
2019-04-13	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−6,875 sh	—	—	0
2019-02-22	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+11.4K sh	—	—	65,814
2019-02-22	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−3,939 sh	$16.81	−$66.2K	61,875
2019-02-22	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−11.4K sh	—	—	22,784
2019-02-14	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+7,809 sh	—	—	57,122
2019-02-14	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−2,700 sh	$16.54	−$44.7K	54,422
2019-02-14	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−7,809 sh	—	—	23,425
2019-02-12	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, GC	AAward	+71.6K sh	—	—	71,602
2019-02-12	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, GC	AAward	+37.5K sh	—	—	37,538
2019-02-03	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+15.4K sh	—	—	54,971
2019-02-03	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−5,658 sh	$16.12	−$91.2K	49,313
2019-02-03	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−15.4K sh	—	—	15,413
2018-04-13	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+6,875 sh	—	—	41,935
2018-04-13	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−2,377 sh	$19.37	−$46K	39,558
2018-04-13	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−6,875 sh	—	—	6,875
2018-02-22	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+11.4K sh	—	—	38,999
2018-02-22	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−3,939 sh	$19.28	−$75.9K	35,060
2018-02-22	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−11.4K sh	—	—	34,176
2018-02-14	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, GC	AAward	+54.8K sh	—	—	54,780
2018-02-14	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, GC	AAward	+31.2K sh	—	—	31,234
2018-02-03	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+15.4K sh	—	—	33,212
2018-02-03	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−5,605 sh	$18.37	−$103K	27,607
2018-02-03	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−15.4K sh	—	—	30,826
2017-04-13	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+6,875 sh	—	—	20,382
2017-04-13	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−2,583 sh	$12.81	−$33.1K	17,799
2017-04-13	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−6,875 sh	—	—	13,750
2017-02-22	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	SVP, GC	AAward	+72.9K sh	—	—	72,925
2017-02-22	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsA Award	SVP, GC	AAward	+45.6K sh	—	—	45,568
2017-02-03	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+15.4K sh	—	—	19,705
2017-02-03	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−6,198 sh	$12.26	−$76K	13,507
2017-02-03	HALOHALOZYME THERAPEUTICS, INC. · Restricted Stock UnitsM Exercise/Conversion	SVP, GC	MExercise/Conversion	−15.4K sh	—	—	46,239
2016-04-13	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	SVP, GC	MExercise/Conversion	+6,875 sh	—	—	6,875
2016-04-13	HALOHALOZYME THERAPEUTICS, INC.F Tax Payment	SVP, GC	FTax Payment	−2,583 sh	$11.76	−$30.4K	4,292

Recent filings

Accepted (ET)
Jan 84
LEONHARDT HARRY J0001415889-25-001082
SEC(opens sec.gov)
Mar 44
LEONHARDT HARRY J0000950170-24-024921
SEC(opens sec.gov)
Mar 24
LEONHARDT HARRY J0001209191-23-014906
SEC(opens sec.gov)
Mar 14
LEONHARDT HARRY J0001209191-22-014378
SEC(opens sec.gov)
Feb 54
LEONHARDT HARRY J0001209191-21-008138
SEC(opens sec.gov)
Apr 154
LEONHARDT HARRY J0001179110-19-004936
SEC(opens sec.gov)
Feb 224
LEONHARDT HARRY J0001179110-19-002464
SEC(opens sec.gov)

Companies

Address

9360 TOWNE CENTRE DR

SAN DIEGO, CA, 92121